Publications by authors named "Murray Epstein"

Claim this Profile
W
Why 25-dehydroxyvitamin D is a negative acute-phase reactant.
Maria J Antonelli, Irving Kushner, Murray Epstein

Cleve Clin J Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patiromer Treatment in Patients With CKD, Hyperkalemia, and Hyperphosphatemia: A Post Hoc Analysis of 3 Clinical Trials.
David A Bushinsky, Jeffrey J Budden, Philip A Kalra, Jinwei Yuan, Carol Moreno Quinn, Murray Epstein

Am J Kidney Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The constellation of vitamin D, the acute-phase response, and inflammation.
Maria J Antonelli, Irving Kushner, Murray Epstein

Cleve Clin J Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aldosterone, Mineralocorticoid Receptor Activation, and CKD: A Review of Evolving Treatment Paradigms.
Murray Epstein, Csaba P Kovesdy, Catherine M Clase, Manish M Sood, Roberto Pecoits-Filho

Am J Kidney Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microalbuminuria Constitutes a Clinical Action Item for Clinicians in 2021.
Peter Rossing, Murray Epstein

Am J Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Podcast Discussing Aldosterone and Mineralocorticoid Receptor Antagonists in 2021: A Paradigm Shift.
Murray Epstein

Diabetes Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets.
Morley D Hollenberg, Murray Epstein

Kidney Int Suppl (2011)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations for the future: current and future treatment paradigms with mineralocorticoid receptor antagonists-unmet needs and underserved patient cohorts.
Murray Epstein

Kidney Int Suppl (2011)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperkalemia with Mineralocorticoid Receptor Antagonist Use in People with CKD: Understanding and Mitigating the Risks.
Murray Epstein, Roberto Pecoits-Filho, Catherine M Clase, Manish M Sood, Csaba P Kovesdy

Clin J Am Soc Nephrol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A promise unfulfilled: the use of mineralocorticoid receptor antagonists in patients with heart failure and a reduced left ventricular ejection fraction.
Bertram Pitt, Murray Epstein

Eur J Heart Fail· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aldosterone and Mineralocorticoid Receptor Signaling as Determinants of Cardiovascular and Renal Injury: From Hans Selye to the Present.
Murray Epstein

Am J Nephrol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The intersection of mineralocorticoid receptor activation and the FGF23-Klotho cascade: a duopoly that promotes renal and cardiovascular injury.
Murray Epstein, Michael Freundlich

Nephrol Dial Transplant· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatorenal syndrome: a historical appraisal of its origins and conceptual evolution.
Garabed Eknoyan, Murray Epstein

Kidney Int· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renin-Angiotensin-Aldosterone System Inhibition and Mineralocorticoid Receptor Antagonists: The Overriding Importance of Enablers and Dampers.
Murray Epstein

Kidney Int Rep· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: "Mortality Attributed to COVID-19 in High-Altitude Populations" by Woolcott and Bergman.
Gustavo Zubieta-Calleja, Alfredo Merino-Luna, Natalia Zubieta-DeUrioste, N Freddy Armijo-Subieta, Jorge Soliz, Murray Epstein

High Alt Med Biol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Decline of the Experimental Paradigm During the COVID-19 Pandemic: A Template for the Future.
João Pedro Ferreira, Murray Epstein, Faiez Zannad

Am J Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avoiding the termination of ACTT.
Murray Epstein

Eur Heart J· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Josep Trueta and Renal Sympathetic Activation.
Murray Epstein

Eur Heart J· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.
A H Jan Danser, Murray Epstein, Daniel Batlle

Hypertension· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the Optimal Dialysis Regimen for Improving Left Ventricular Structure and Function: An Urgent Need.
Murray Epstein, David L Epstein, Daniel Duprez

J Card Fail· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Norman K. Hollenberg, MD PhD (1936-2020).
Murray Epstein

Eur Heart J· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics.
Matthew R Weir, Martha R Mayo, Dahlia Garza, Susan A Arthur, Lance Berman, Murray Epstein

J Hypertens· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistant Hypertension: Insights on Evaluation and Management in the Post-SPRINT (Systolic Blood Pressure Intervention Trial) Era.
Raymond R Townsend, Murray Epstein

Hypertension· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the future.
Patrick Rossignol, Matthieu Legrand, Mikhail Kosiborod, Steven M Hollenberg, W Frank Peacock, Murray Epstein

Pharmacol Res· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of clinical outcomes and costs based on prescribed dose level of renin-angiotensin-aldosterone system inhibitors.
Murray Epstein, Paula J Alvarez, Nancy L Reaven, Susan E Funk, Karen J McGaughey

Am J Manag Care· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis